Cycloastragalol is the main hydrolytic metabolite and absorbed component of astragaloside IV in the intestine, with a relatively small molecular weight and strong lipophilicity, which is beneficial for biofilm penetration and gastrointestinal absorption to achieve better bioavailability. Numerous modern medical studies have shown that astragaloside IV can alleviate ischemia-reperfusion brain tissue damage by enhancing the body's ability to scavenge oxygen free radicals, inhibiting peroxidation, and reducing neuronal calcium overload.

OEM powder capsules